Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-stage Renal Disease, and Non-AIDS-defining Cancer in HIV-infected Versus Uninfected Adults
Overview
Authors
Affiliations
Background: Although it has been shown that human immunodeficiency virus (HIV)-infected adults are at greater risk for aging-associated events, it remains unclear as to whether these events happen at similar, or younger ages, in HIV-infected compared with uninfected adults. The objective of this study was to compare the median age at, and risk of, incident diagnosis of 3 age-associated diseases in HIV-infected and demographically similar uninfected adults.
Methods: The study was nested in the clinical prospective Veterans Aging Cohort Study of HIV-infected and demographically matched uninfected veterans, from 1 April 2003 to 31 December 2010. The outcomes were validated diagnoses of myocardial infarction (MI), end-stage renal disease (ESRD), and non-AIDS-defining cancer (NADC). Differences in mean age at, and risk of, diagnosis by HIV status were estimated using multivariate linear regression models and Cox proportional hazards models, respectively.
Results: A total of 98 687 (31% HIV-infected and 69% uninfected) adults contributed >450 000 person-years and 689 MI, 1135 ESRD, and 4179 NADC incident diagnoses. Mean age at MI (adjusted mean difference, -0.11; 95% confidence interval [CI], -.59 to .37 years) and NADC (adjusted mean difference, -0.10 [95% CI, -.30 to .10] years) did not differ by HIV status. HIV-infected adults were diagnosed with ESRD at an average age of 5.5 months younger than uninfected adults (adjusted mean difference, -0.46 [95% CI, -.86 to -.07] years). HIV-infected adults had a greater risk of all 3 outcomes compared with uninfected adults after accounting for important confounders.
Conclusions: HIV-infected adults had a higher risk of these age-associated events, but they occurred at similar ages than those without HIV.
Seidel H, Benson D, Litvak A, Lee M, El Dafrawy M N Am Spine Soc J. 2025; 21:100577.
PMID: 40026323 PMC: 11872388. DOI: 10.1016/j.xnsj.2024.100577.
Individualizing Antiretroviral Therapy in the Older Patient.
Hoy J Drugs Aging. 2024; 42(1):9-20.
PMID: 39673014 DOI: 10.1007/s40266-024-01168-z.
Markakis K, Tsachouridou O, Georgianou E, Pilalas D, Nanoudis S, Metallidis S Life (Basel). 2024; 14(11).
PMID: 39598166 PMC: 11595778. DOI: 10.3390/life14111367.
Veksler V, Leon-Rivera R, Fleysher L, Gonzalez J, Lopez J, Rubin L JCI Insight. 2024; 9(17).
PMID: 39253970 PMC: 11385088. DOI: 10.1172/jci.insight.179855.
Pirsl F, Calkins K, Rudolph J, Wentz E, Xu X, Lau B AIDS Care. 2024; 36(11):1657-1667.
PMID: 39079500 PMC: 11511642. DOI: 10.1080/09540121.2024.2383875.